Maureen Kanzler

800 total citations
19 papers, 616 citations indexed

About

Maureen Kanzler is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Maureen Kanzler has authored 19 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Maureen Kanzler's work include Smoking Behavior and Cessation (7 papers), Treatment of Major Depression (4 papers) and Bipolar Disorder and Treatment (3 papers). Maureen Kanzler is often cited by papers focused on Smoking Behavior and Cessation (7 papers), Treatment of Major Depression (4 papers) and Bipolar Disorder and Treatment (3 papers). Maureen Kanzler collaborates with scholars based in United States. Maureen Kanzler's co-authors include Jerome H. Jaffe, Sidney Malitz, Paolo Decina, Harold A. Sackeïm, B. Kerr, John Green, Karl Verebey, John J. Langone, Larry S. Friedman and Isak Prohovnik and has published in prestigious journals such as American Journal of Psychiatry, Annals of the New York Academy of Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Maureen Kanzler

19 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Kanzler United States 13 285 245 154 81 77 19 616
Helen A. Shaw United States 8 404 1.4× 264 1.1× 206 1.3× 60 0.7× 78 1.0× 17 887
Laurie Barclay United States 15 353 1.2× 52 0.2× 240 1.6× 84 1.0× 118 1.5× 34 863
Pier Luigi Scapicchio Italy 7 305 1.1× 123 0.5× 104 0.7× 21 0.3× 72 0.9× 12 521
Lara Schneider United States 5 481 1.7× 275 1.1× 241 1.6× 48 0.6× 107 1.4× 6 775
E Łuczywek Poland 10 270 0.9× 61 0.2× 264 1.7× 104 1.3× 57 0.7× 28 622
Sandra Vicari United States 14 238 0.8× 148 0.6× 225 1.5× 39 0.5× 37 0.5× 14 859
F. Latour France 12 318 1.1× 84 0.3× 159 1.0× 37 0.5× 55 0.7× 28 577
R.S. Goldman United States 7 290 1.0× 123 0.5× 158 1.0× 38 0.5× 87 1.1× 20 517
Lars Molander Sweden 16 150 0.5× 108 0.4× 257 1.7× 240 3.0× 16 0.2× 25 743
W. C. McCormick United States 7 338 1.2× 41 0.2× 202 1.3× 98 1.2× 61 0.8× 11 686

Countries citing papers authored by Maureen Kanzler

Since Specialization
Citations

This map shows the geographic impact of Maureen Kanzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Kanzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Kanzler more than expected).

Fields of papers citing papers by Maureen Kanzler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Kanzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Kanzler. The network helps show where Maureen Kanzler may publish in the future.

Co-authorship network of co-authors of Maureen Kanzler

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Kanzler. A scholar is included among the top collaborators of Maureen Kanzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Kanzler. Maureen Kanzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sackeïm, Harold A., Paolo Decina, Maureen Kanzler, B. Kerr, & Sidney Malitz. (1987). Effects of electrode placement on the efficacy of titrated, low-dose ECT. American Journal of Psychiatry. 144(11). 1449–1455. 194 indexed citations
2.
Malitz, Sidney, Harold A. Sackeïm, Paolo Decina, Maureen Kanzler, & Barbara A. Kerr. (1986). The Efficacy of Electroconvulsive Therapya. Annals of the New York Academy of Sciences. 462(1). 56–64. 25 indexed citations
3.
Sackeïm, Harold A., Paolo Decina, Isak Prohovnik, et al.. (1986). Dosage, Seizure Threshold, and the Antidepressant Efficacy of Electroconvulsive Therapya. Annals of the New York Academy of Sciences. 462(1). 398–410. 49 indexed citations
4.
Kanzler, Maureen, et al.. (1983). Low nicotine cigarettes: Cigarette consumption and breath carbon monoxide after one year. Clinical Pharmacology & Therapeutics. 34(3). 408–415. 8 indexed citations
5.
Verebey, Karl, et al.. (1982). A Rapid, Quantitative GLC Method for the Simultaneous Determination of Nicotine and Cotinine. Journal of Analytical Toxicology. 6(6). 294–296. 33 indexed citations
6.
Jaffe, Jerome H., et al.. (1982). Money and Health Messages as Incentives for Smoking Low Tar/Nicotine Cigarettes: Changes in Consumption and Exhaled Carbon Monoxide. British Journal of Addiction. 77(1). 21–34. 3 indexed citations
7.
Jaffe, Jerome H., Maureen Kanzler, Ronald Brady, & Larry S. Friedman. (1982). Methodology for assessing agents that suppress methadone withdrawal: A study of baclofen.. PsycEXTRA Dataset. 41. 269–75. 3 indexed citations
8.
Jaffe, Jerome H., Maureen Kanzler, Larry S. Friedman, Albert J. Stunkard, & Karl Verebey. (1981). Carbon monoxide and thiocyanate levels in low tar/nicotine smokers. Addictive Behaviors. 6(4). 337–343. 30 indexed citations
9.
Jaffe, Jerome H., Maureen Kanzler, & John Green. (1981). Abuse potential of loperamide: adaptation of established evaluative methods to volunteer subjects.. PubMed. 34. 232–40. 2 indexed citations
10.
Jaffe, Jerome H., Maureen Kanzler, & John Green. (1980). Abuse potential of loperamide. Clinical Pharmacology & Therapeutics. 28(6). 812–819. 66 indexed citations
11.
Natale, Michael, Maureen Kanzler, Jerome H. Jaffe, & Joseph Jaffe. (1980). Acute Effects of Alcohol on Defensive and Primary-Process Language. Results with Three Human Volunteers. International Journal of the Addictions. 15(7). 1055–1067. 7 indexed citations
12.
Jaffe, Jerome H. & Maureen Kanzler. (1979). Smoking as an addictive disorder.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4–23. 26 indexed citations
13.
Jaffe, Jerome H., et al.. (1978). Inducing Low Tar/Nicotine Cigarette Smoking in Women. British Journal of Addiction to Alcohol & Other Drugs. 73(3). 271–281. 12 indexed citations
14.
Jaffe, Jerome H., et al.. (1977). Nicotine: Cotinine levels in blood during cessation of smoking. Comprehensive Psychiatry. 18(1). 93–101. 37 indexed citations
15.
Kanzler, Maureen, et al.. (1976). Response of medical personnel to an on‐site smoking cessation program. Journal of Clinical Psychology. 32(3). 670–674. 21 indexed citations
16.
Kanzler, Maureen, et al.. (1976). Long– and short–term effectiveness of a large–scale proprietary smoking cessation program—a 4-year follow-up of smokenders participants. Journal of Clinical Psychology. 32(3). 661–669. 42 indexed citations
17.
Kanzler, Maureen, et al.. (1974). Imipramine steady-state studies and plasma binding.. PubMed. 9(0). 457–61. 2 indexed citations
18.
Malitz, Sidney & Maureen Kanzler. (1971). Are Antidepressants Better Than Placebo?. American Journal of Psychiatry. 127(12). 1605–1611. 28 indexed citations
19.
Wharton, Ralph N., et al.. (1971). Clinical and Metabolic Studies with Imipramine in Man. American Journal of Psychiatry. 127(10). 1321–1326. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen A. Shaw Breakdown of academic impact, for papers by Laurie Barclay Breakdown of academic impact, for papers by Pier Luigi Scapicchio Breakdown of academic impact, for papers by Lara Schneider Breakdown of academic impact, for papers by E Łuczywek Breakdown of academic impact, for papers by Sandra Vicari Breakdown of academic impact, for papers by F. Latour Breakdown of academic impact, for papers by R.S. Goldman Breakdown of academic impact, for papers by Lars Molander Breakdown of academic impact, for papers by W. C. McCormick
Rankless by CCL
2026